Scott Marsh Financial’s Idexx Laboratories IDXX Stock Holding History

Scott Marsh Financial’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.31M	Buy	+2,448	New	+$1.17M	0.49%	58

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Scott Marsh Financial's IDXX Position: Q2 2025 in Review

Scott Marsh Financial opened a new position in Idexx Laboratories (IDXX) in Q2 2025: 2,448 shares worth $1.31M. The stake represents 0.49% of the portfolio and ranks #58 among its holdings.

1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

Scott Marsh Financial held 2,448 shares of Idexx Laboratories worth $1.31M as of Q2 2025.
Idexx Laboratories was a new Scott Marsh Financial position in Q2 2025.
Idexx Laboratories made up 0.49% of Scott Marsh Financial's portfolio in Q2 2025, its #58 holding.
1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Scott Marsh Financial's 13F filing for Q2 2025, filed 14 Aug 2025.